Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Latest Generation Acoustic Biosensors Launched in Europe

By LabMedica International staff writers
Posted on 05 Oct 2011
The latest addition to a line of acoustic biosensors is now available for purchase by European biotech researchers and other life scientists.

Acoustic biosensors do not require complex labeling methods; they are real-time analytical systems rather than equilibrium and can be used to investigate living cells rather than fixed cells or purified proteins. More...
A leader in the field of acoustic biosensors, SAW Instruments GmbH (Bonn, Germany), recently unveiled the samX, the latest high-end addition to the sam range of acoustic biosensors. The samX features eight analysis channels and adaptable routing that expands the workflow options available for increased power and flexibility.

The new system uses SAW’s proven proprietary surface acoustic wave technology to detect mass binding and protein conformational changes on whole cells. Surface acoustic wave technology is based on the ability of a wave of energy to travel across the surface of a material. Each surface has a typical inherent elasticity affecting the way the energy of the wave dissipates as it travels across the surface of the material being analyzed. The technology developed and employed by SAW instruments is capable of accurately interpreting this information in order to provide real time readouts measuring binding and conformational changes in the samples through which the wave passes.

The new samX has two sensor chips for higher-end users, rather than the single chip of existing sam5 models, increasing the number of channels to eight, further facilitating the parallel processing of samples. In addition, different ligands can now be immobilized on-line at each chip position automatically, without the need for time-consuming, off-line protein loading.

Dr Markus Perpeet, managing director of SAW, said, “We are very excited to introduce users to the samX, which further extends the flexibility offered by our range of biosensors. The new system facilitates more complex assay design and can be easily adapted to meet the needs of each user, while increasing throughput speed and accuracy. It is particularly well suited to providing binding constants and kinetics data for ligands binding to membrane targets on cells, while results are obtained significantly faster than those from equilibrium-based methods.”

Related Links:
SAW Instruments GmbH



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.